Alprazolam and placebo differed significantly on the Clinician-Administered PTSD Scale score at posttreatment and PTSD diagnosis at @ months posttreatment ; the alprazolam group showed a higher rate of PTSD ( @ % ) than the placebo group ( @ % ) .